Personal view, short selling won’t be a big problem for FY21 and FY22. Obviously MYX is conservative about FDA approvals this time, as lessons learnt from last. Too risky to short when two big hits in the pipeline.
Ann: Change in substantial holding, page-4
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.47 |
Change
0.060(1.36%) |
Mkt cap ! $382.8M | |||
| Open | High | Low | Value | Volume |
| $4.43 | $4.54 | $4.42 | $953.7K | 213.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2737 | $4.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.16 | 216 | 1 |
View Market Depth
| Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |